Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 06 2019
Historique:
received: 04 02 2019
accepted: 31 03 2019
pubmed: 12 4 2019
medline: 24 6 2020
entrez: 12 4 2019
Statut: epublish

Résumé

Low-risk human papillomaviruses (LR-HPVs) are the causative agents of genital warts, which are a widespread sexually transmitted disease. How LR-HPVs affect autophagy and the specific proteins involved are unknown. In the current study, we investigated the impact of LR-HPV11 early protein 6 (E6) on the activity of the autophagy pathway. We transfected an HPV11 E6 (11E6) plasmid into HaCaT cells, H8 cells, and NHEK cells and established a stable cell line expressing the HPV11 E6 protein. The differences in autophagy activity and upstream regulatory pathways compared with those in the parent cell lines were investigated using a Western blot analysis of the total and phosphorylated protein levels and confocal microscopy of immunostained cells and cells transfected with an mCherry-green fluorescent protein-LC3 expression plasmid. We used short hairpin RNA (shRNA) to knock down 11E6 and showed that these effects require continued 11E6 expression. Compared with its expression in the control cells, the expression of HPV11 E6 in the cells activated the autophagy pathway. The increased autophagy activity was the result of the decreased phosphorylation levels of the canonical autophagy repressor mammalian target of rapamycin (mTOR) at its Ser2448 position (the mTOR complex 1 [mTORC1] phosphorylation site) and decreased AKT and Erk phosphorylation. Therefore, these results indicate that HPV11 E6 activates autophagy through the AKT/mTOR and Erk/mTOR pathways. Our findings provide novel insight into the relationship between LR-HPV infections and autophagy and could help elucidate the pathogenic mechanisms of LR-HPV.

Identifiants

pubmed: 30971468
pii: JVI.00172-19
doi: 10.1128/JVI.00172-19
pmc: PMC6613752
pii:
doi:

Substances chimiques

E6 protein, Human papillomavirus type 11 0
Oncogene Proteins, Viral 0
MTOR protein, human EC 2.7.1.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

J Gen Virol. 1999 Jun;80 ( Pt 6):1513-7
pubmed: 10374970
J Virol. 1999 Sep;73(9):7297-307
pubmed: 10438818
Oncogene. 2000 Apr 13;19(16):2014-22
pubmed: 10803462
Int J Cancer. 2001 Mar 15;91(6):822-7
pubmed: 11275986
J Virol. 2002 Apr;76(7):3350-8
pubmed: 11884560
Cancer Res. 2002 Dec 1;62(23):7075-82
pubmed: 12460929
J Biol Chem. 2003 Mar 21;278(12):10731-6
pubmed: 12524447
J Virol. 2003 Apr;77(8):4818-26
pubmed: 12663788
J Virol. 2004 Feb;78(4):2142-51
pubmed: 14747580
J Virol. 2004 Mar;78(5):2620-6
pubmed: 14963169
Intervirology. 2004;47(1):48-56
pubmed: 15044836
Cell. 2004 Jul 23;118(2):257-70
pubmed: 15260994
Int J Mol Med. 2005 Oct;16(4):767-70
pubmed: 16142419
Virology. 2007 Feb 20;358(2):303-10
pubmed: 17023019
Nat Rev Mol Cell Biol. 2007 Nov;8(11):931-7
pubmed: 17712358
Am J Pathol. 2008 Sep;173(3):682-8
pubmed: 18688031
Virology. 2009 Feb 20;384(2):335-44
pubmed: 19007963
Oncogene. 2008 Nov 24;27(55):7018-30
pubmed: 19029942
Adv Virus Res. 2008;72:155-205
pubmed: 19081491
Virology. 2009 Feb 20;384(2):260-5
pubmed: 19135222
Virology. 2009 Mar 1;385(1):192-7
pubmed: 19135224
Front Biosci (Landmark Ed). 2009 Jan 01;14:900-17
pubmed: 19273107
Brain Res. 2009 Dec 11;1305:1-13
pubmed: 19765562
APMIS. 2010 Jun;118(6-7):471-93
pubmed: 20553529
J Virol. 2010 Sep;84(18):9398-407
pubmed: 20631133
PLoS One. 2010 Sep 17;5(9):null
pubmed: 20862247
PLoS One. 2011 Mar 14;6(3):e17522
pubmed: 21423731
Autophagy. 2011 Jun;7(6):643-4
pubmed: 21460621
Cancer. 2011 Dec 1;117(23):5412-22
pubmed: 21590687
Cell. 1990 Dec 21;63(6):1129-36
pubmed: 2175676
Mol Cell Biol. 2012 Jan;32(1):2-11
pubmed: 22025673
J Virol. 2012 Mar;86(6):3276-83
pubmed: 22238312
Virology. 2012 Mar 15;424(2):77-98
pubmed: 22284986
J Pharmacol Sci. 2012;118(4):479-86
pubmed: 22447306
Structure. 2012 Apr 4;20(4):604-17
pubmed: 22483108
Arch Gynecol Obstet. 2012 Nov;286(5):1261-7
pubmed: 22718097
Nature. 2012 Aug 30;488(7413):S2-3
pubmed: 22932437
J Mol Microbiol Biotechnol. 2012;22(4):245-57
pubmed: 23036990
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23
pubmed: 23199955
Vaccine. 2012 Nov 20;30 Suppl 5:F55-70
pubmed: 23199966
J Virol. 2013 Mar;87(5):2508-17
pubmed: 23255786
Virology. 2013 Mar 1;437(1):12-9
pubmed: 23290079
Biochem Biophys Res Commun. 2013 Apr 19;433(4):385-9
pubmed: 23537650
Antioxid Redox Signal. 2014 Jan 20;20(3):460-73
pubmed: 23725295
J Pathol. 2013 Nov;231(3):354-66
pubmed: 23913724
Expert Opin Ther Targets. 2013 Nov;17(11):1357-68
pubmed: 24094136
Mol Psychiatry. 2014 Sep;19(9):1001-9
pubmed: 24126929
Mol Cell. 2013 Dec 12;52(5):679-92
pubmed: 24211266
J Hepatol. 2014 May;60(5):1002-9
pubmed: 24365171
Neoplasia. 2013 Dec;15(12):1354-62
pubmed: 24403857
Cells. 2013 Jan 25;2(1):83-104
pubmed: 24709646
Cancer Discov. 2014 Aug;4(8):914-27
pubmed: 24875857
Semin Cell Dev Biol. 2014 Dec;36:121-9
pubmed: 25158238
Oncol Rep. 2015 Jan;33(1):95-102
pubmed: 25333815
J Clin Invest. 2015 Jan;125(1):42-6
pubmed: 25654549
Autophagy. 2015;11(3):503-15
pubmed: 25714412
Rev Med Virol. 2015 Mar;25 Suppl 1:2-23
pubmed: 25752814
Virology. 2015 May;479-480:450-6
pubmed: 25858140
Growth Factors. 2015;33(5-6):326-36
pubmed: 26431359
J Biol Chem. 2016 Jan 8;291(2):904-12
pubmed: 26565022
Nature. 2016 Jan 28;529(7587):541-5
pubmed: 26789255
Mutat Res Rev Mutat Res. 2017 Apr - Jun;772:36-50
pubmed: 28528689
Clin Sci (Lond). 2017 Aug 10;131(17):2201-2221
pubmed: 28798073
Oncogenesis. 2017 Aug 28;6(8):e374
pubmed: 28846079
Cell Oncol (Dordr). 2018 Jun;41(3):253-268
pubmed: 29299828
Nat Commun. 2018 Mar 28;9(1):1268
pubmed: 29593293
Nature. 1985 Mar 7-13;314(6006):111-4
pubmed: 2983228
Int J Mol Sci. 2018 Jun 15;19(6):null
pubmed: 29914057
Sci Signal. 2018 Sep 18;11(548):null
pubmed: 30228226
J Virol. 1987 Apr;61(4):962-71
pubmed: 3029430
EMBO J. 1987 Apr;6(4):989-92
pubmed: 3036495
Cell. 1993 Nov 5;75(3):495-505
pubmed: 8221889
J Virol. 1996 Feb;70(2):683-8
pubmed: 8551603
Nature. 1996 Mar 7;380(6569):79-82
pubmed: 8598912
J Virol. 1996 Jul;70(7):4509-16
pubmed: 8676476
Virology. 1997 Nov 10;238(1):40-52
pubmed: 9375007

Auteurs

Boya Zhang (B)

Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Yinjing Song (Y)

Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Siyuan Sun (S)

Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Rui Han (R)

Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Chunting Hua (C)

Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Stijn van der Veen (S)

Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China stijnvanderveen@zju.edu.cn chenghao1@zju.edu.cn.
Department of Microbiology and Parasitology, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Medicine, Zhejiang University, Hangzhou, China.

Hao Cheng (H)

Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China stijnvanderveen@zju.edu.cn chenghao1@zju.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH